ClearPoint Neuro und UCB unterzeichnen Lizenzvereinbarung für die Verabreichung von Gentherapeutika
25. Mai 2023 08:51 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Kalifornien, May 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT), ein weltweit tätiges Unternehmen, das Neuronavigationssysteme für die Durchführung von Eingriffen...
ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
24. Mai 2023 09:25 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) a global therapy-enabling platform company providing navigation and delivery to the brain, today...
ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference
18. Mai 2023 16:01 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 18, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro Reports First Quarter 2023 Results
11. Mai 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro to Present Investigational Research and Showcase Novel Innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles
10. Mai 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro to Announce First Quarter 2023 Results May 11, 2023
28. April 2023 16:42 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro to Showcase Two Novel Innovations at AANS 2023: ClearPoint Maestro® Brain Model and ClearPoint Prism™ Neuro Laser Therapy System
20. April 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro Announces Agreement with NE Scientific to Integrate Gene Therapy Infusion Coverage Tool into ClearPoint Maestro® Brain Model
18. April 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Portfolio in Brazil
13. April 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
A ClearPoint Neuro Anuncia Aprovação da Carteira de Navegação Neuro pela ANVISA no Brasil
13. April 2023 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Califórnia, April 13, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (a "Empresa"), uma empresa de plataforma global que fornece navegação e entrega ao cérebro,...